Trends in patient cost sharing for clinical services used as quality indicators

Journal of General Internal Medicine

Volumn 25, Issue 3, 2010, Pages 243-248

  Chernew, Michael ^a   Gibson, Teresa B ^b   Fendrick, A Mark ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Thomson Reuters ^*  (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Copayments; Costs; Payments

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; DRUG COST; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH SERVICE; PRESCRIPTION; TREND STUDY;

ADOLESCENT; ADULT; AGED; COST SHARING; DATABASES, FACTUAL; FEMALE; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; YOUNG ADULT;

EID: 77951113133     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-1219-y     Document Type: Article

References (14)

1. Prescription Drug Trends 2007 Update, Kaiser Family Foundation. 2007. (Available from: http://www.kff.org/rxdrugs/index.cfm.) Accessed December 1, 2009.
2. JC Robinson 2005 Health savings accounts - the ownership society in health care New England Journal of Medicine 353 12 1199 1202 10.1056/NEJMp058097 1:CAS:528:DC%2BD2MXhtVelt7jJ 16177245
3. ME Chernew JP Newhouse 2008 What does the RAND health insurance experiment tell us about the impact of patient cost sharing on health outcomes? American Journal of Management Care 14 7 412 414
4. D Goldman G Joyce, et al. 2004 Pharmacy benefits and the use of drugs by the chronically Ill JAMA 291 2344 2350 10.1001/jama.291.19.2344 1:CAS:528:DC%2BD2cXkt1Sjs70%3D 15150206
5. T Gibson R Ozminkowski R Goetzel 2005 The effects of prescription drug cost sharing: a review of the evidence American Journal of Managed Care 11 730 740 16268755
6. AM Fendrick DG Smith ME Chernew SN Shah 2001 A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost American Journal of Managed Care 7 861 867 1:STN:280: DC%2BD3MritlGqtw%3D%3D 11570020
7. JD Kleinke 2004 Access versus excess: value-based cost sharing for prescription drugs Health Affairs 23 34 47 10.1377/hlthaff.23.1.34 1:STN:280:DC%2BD2c7ht1Cmug%3D%3D 15002626
8. AM Fendrick ME Chernew 2006 Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment American Journal of Managed Care 12 1 7
9. Chernew ME, Rosen, AB, Fendrick, AM. Value-based insurance design: Health Aff. published 30 January 2007, 10.1377/hlthaff.26.2.w195.
10. CC Denny EJ Emanuel SD Pearson 2007 Why well-insured patients should demand value-based insurance benefits JAMA 297 2515 2518 10.1001/jama.297.22. 2515 1:CAS:528:DC%2BD2sXmsV2msbk%3D 17565086
11. Freudenheim M. Some Employers Are Offering Free Drugs. New York Times. February 21, 2007; Page A1.
12. Fuhrmans V. New tack on copays: cutting them. Wall Street Journal. May 8, 2007; Page D1.
13. ME Chernew MR Shah A Wegh SN Rosenberg IA Juster AB Rosen MC Sokol K Yu-Isenberg AM Fendrick 2008 Impact of decreasing copayments on medication adherence within a disease management environment Health Affairs 27 103 112 10.1377/hlthaff.27.1.103 18180484
14. United States Senate Bill 1040. Available at http://frwebgate.access.gpo. gov/cgi-bin/getdoc.cgi?dbname=111-cong-bills&docid=f:s1040is.txt.pdf Accessed October 14, 2009.